M&T Bank’s GSK GSK Stock Holding History

M&T Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16	Closed	-$6K	–	1608
2019 Q4	$6K	Hold	16	–	–	﹤0.01%	1379
2019 Q3	$3K	Buy	+16	New	+$823	﹤0.01%	1580
2019 Q2	–	Sell	-16	Closed	-$1K	–	1637
2019 Q1	$1K	Buy	+16	New	+$800	﹤0.01%	1581
2018 Q2	–	Sell	-8	Closed	-$1K	–	1584
2018 Q1	$1K	Buy	+8	New	+$373	﹤0.01%	1556

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

M&T Bank's GSK Position: Q1 2026 in Review

M&T Bank reduced its GSK (GSK) stake by 2.5% in Q1 2026, selling an estimated $55.7K and leaving 40,799 shares worth $2.25M. The position accounts for 0.01% of the portfolio, ranked #569.

M&T Bank first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $34M in Q3 2017. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

M&T Bank held 40,799 shares of GSK worth $2.25M as of Q1 2026.
M&T Bank sold 1,028 GSK shares in Q1 2026, an estimated $55.7K.
GSK made up 0.01% of M&T Bank's portfolio in Q1 2026, its #569 holding.
M&T Bank first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
M&T Bank's GSK position peaked at $34M in Q3 2017.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.